CUTANEOUS T CELL LYMPHOMA (CTCL)
Clinical trials for CUTANEOUS T CELL LYMPHOMA (CTCL) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS T CELL LYMPHOMA (CTCL) trials appear
Sign up with your email to follow new studies for CUTANEOUS T CELL LYMPHOMA (CTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental antibody targets Tough-to-Treat skin cancer in early trial
Disease control Not yet recruitingThis early-stage trial is testing a new antibody called DT-7012 for people with advanced cutaneous T-cell lymphoma (CTCL), a type of skin cancer, that has come back or hasn't responded to at least two previous treatments. The study aims to find a safe dose and see if the antibody…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: EARLY_PHASE1 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New strategy aims to stop deadly skin cancer from coming back
Disease control Not yet recruitingThis study tests if giving the drug brentuximab vedotin as a preventive treatment after a stem cell transplant can stop an aggressive type of skin cancer (CTCL) from returning. It will involve 84 adults whose cancer had responded to prior treatments but is at high risk of relapse…
Matched conditions: CUTANEOUS T CELL LYMPHOMA (CTCL)
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC